Sertraline for depression after acute MI

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1352, 2002-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute and continuation therapy with sertraline in major depression: a large-scale multicenter study

By Floris M.   De Nayer A.R.   Janssen F.   Van Houdenhove B.   Iancu H.   Boxus A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 308-309

Elsevier

Access to resources Recommend Favorite

Secondary prevention after acute MI

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Optimising treatment after acute MI in patients with diabetes

By  

Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Pexelizumab: reduced mortality rate after acute MI

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Eplerenone reduces morbidity, mortality after acute MI

By  

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite